A Safety and Efficacy Study in Patients With Gastric Cancer

NCT00400179 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1053

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S-1/Cisplatin
DRUG: 5-FU/cisplatin

Sponsor

Taiho Oncology, Inc.

Collaborators

[object Object]